NUCLEO
The first agentic platform for oncology
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- nucleoresearch.com
- Total Funding
- $500K
About
Nucleo builds AI agents that extract oncological metrics from CT scans—including sarcopenia detection, body composition, and lesion classification—enabling 2,500x faster segmentation than manual workflows. Working with Stanford Hospital, Cedars-Sinai, UCI Health, and Weill Cornell, Nucleo aims to compress the cancer diagnostic interval from 9–11 weeks to under 10 days.
Tech Stack
Backend
Python
AI/ML
PyTorch
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account